NCT00270049View on ClinicalTrials.gov

Epoetin Alfa for the Treatment of Anemia Resulting From Chronic Lymphocytic Leukemia

PHASE2CompletedINTERVENTIONAL

Enrollment

195

Participants

Timeline

Start Date

November 30, 1990

Study Completion Date

January 31, 1994

Conditions

AnemiaLeukemia, Lymphocytic, ChronicLeukemia, LymphocyticCancerNeoplasmsQuality of Life

Interventions

DRUG

epoetin alfa

All Listed Sponsors

lead

Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

INDUSTRY